Kantum Pharma
PrivateLast Round
Series A
Jul 12, 2021
Total Funding Raised
$6.73M
Company Overview
Kantum Pharma is a biotechnology company that develops therapeutic treatments and diagnostic tests for acute kidney injury.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kantum Pharma Comparables
Compare Kantum Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Balmes Transplantation | 78% | |
| AM-Pharma | 77% | |
| CFM Pharma Holding B.V. | 76% | |
Kantum Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 12, 2021 | ||||
| Seed | Nov 22, 2019 | ||||
| Grant | Nov 15, 2017 |
Kantum Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SideCar Angels | Series A |
| 10x Venture Partners | Series A |
| Millworks Fund | Series A |
| Broadview Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 12, 2021
$4M round with participation from 10x Venture Partners and Broadview Ventures.
Kantum Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kantum Pharma's valuation, stock price, and market status.